Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone vs Enalapril with Losartan in Diabetic Nephropathy
NCT01667614Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in diabetic nephropathy (DN), sponsored by Tehran University of Medical Sciences. Started May 2010; status: completed.
02
Drugs
spironolactone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01667614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667614.